Skip to main content
Log in

Remarkable improvement of selective mutism with everolimus in a patient with tuberous sclerosis complex

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Sharp WG, Sherman C, Gross AM (2007) Selective mutism and anxiety: a review of the current conceptualization of the disorder. J Anxiety Disord 21(4):568–579

    Article  PubMed  Google Scholar 

  2. Northrup H, Krueger DA, Group ITSCC (2013) Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 49(4):243–254

    Article  PubMed Central  PubMed  Google Scholar 

  3. de Vries PJ, Whittemore VH, Leclezio L, Byars AW, Dunn D, Ess KC, Jansen A (2015) Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND checklist. Pediatr Neurol 52(1):25–35

    Article  PubMed Central  PubMed  Google Scholar 

  4. Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, Jozwiak S (2013) Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 381(9861):125–132

    Article  CAS  PubMed  Google Scholar 

  5. Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Budde K (2013) Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 381(9869):817–824

    Article  CAS  PubMed  Google Scholar 

  6. de Vries PJ, Howe CJ (2007) The tuberous sclerosis complex proteins–a GRIPP on cognition and neurodevelopment. Trends Mol Med 13(8):319–326

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The study was done at Arkansas children’s hospital, little rock, Arkansas.

Conflict of interest

The author declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Ethical standard

The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Informed consent for publication was obtained from the parents of the patient.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Debopam Samanta.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Samanta, D. Remarkable improvement of selective mutism with everolimus in a patient with tuberous sclerosis complex. Acta Neurol Belg 115, 815–817 (2015). https://doi.org/10.1007/s13760-015-0458-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-015-0458-4

Keywords

Navigation